This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Lung crisis in sickle cell anaemia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Sickle cell crises in the lung - otherwise referred to as acute chest syndrome (ACS) - are characterised by pleuritic chest pains, fever, abnormal chest examinations and presence of new infiltrations in the chest X ray (1).

  • is the second most common cause of hospital admission in SCD patients (2)
  • study evidence showed that 50% of patients with sickle cell crises in the lung, had a pain event in the two weeks preceding the event (3)
  • around half of all SCD patients will experience at least one episode of ACS during their lives (4)
  • in some areas, the acute chest syndrome is the commonest cause of death in sickle cell anaemia.

They are of mixed pathology; caused by a combination of infection, fat embolism and vaso occlusion of the pulmonary vasculature (2)

  • mostly seen during early childhood (usually presents with clinical features that are more typical for pneumonia) (2)
  • is a combination of pulmonary infarction, infection, and fat embolism (3)
  • caused by sickling and ischaemia in deep tissues of the chest wall (3)
  • a review describes typical features as fever, acute respiratory signs and symptoms, such as cough, wheezing, dyspnoea, crepitations or chest pain, and consolidation on chest radiograph (3)
  • in later childhood and adulthood, it is more frequent during a painful crises or after anaesthesia (1)

A combination of clinical signs or symptoms of chest consolidation and worsening hypoxia is sufficient for the diagnosis of ACS (since X ray changes often lag behind clinical signs) (4)

Local protocols should be prepared for management of ACS and should include:

  • analgesia
  • monitoring arterial blood gas measurement
  • oxygen and respiratory support - persistent, profound hypoxia is an indication for ventilation.
  • incentive spirometry – useful in SCD patients presenting with chest or back pain above the diaphragm to prevent pulmonary complications
  • fluid management
  • bronchodilator therapy – for patients with evidence of wheeze or reversible airways disease, or a history of asthma
  • antibiotic treatment may be indicated
  • blood transfusion (4)

Longterm treatment with hydroxycarbamide (former British Approved Name, hydroxyurea) has led to a reduction by 50% in acute chest syndrome in some studies.

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.